Dr. John Campbell contends that medical research is often corrupted by financial interests, which results in publication bias and a failure to investigate low-cost, effective treatments.

“The financial motivation sadly is not there. So why a lot of these people died during that period of time. It's probably going to be very difficult to be definitive about, but it is surprising that the way that data was collected changed and the amount of data released was reduced.”

High-dose IV steroids were a proven effective treatment that was unfairly dismissed by Anthony Fauci.

“It was a 36% reduction in death, which is pretty significant when you're in the ICU. The people in the ICU were very very sick. It was a a third of them had a reduction in death by by taking IV steroids. But he was dismissing it from the very beginning”

Corporate medical media and journals are corrupted by financial ties to Big Pharma, leading them to suppress investigations into industry malpractice.

“The corporate media which is bought and paid for that's why they advertise that's why big Pharma advertises on your Co local news station it's not so not to fund them to do investigations it's to fund them so they don't do investigations and they don't say anything bad about big farma”

The dominance of the amyloid cascade hypothesis has limited the development of effective Alzheimer's treatments by prioritizing a single, potentially flawed factor.

“By targeting just one very specific factor, I think we're not having a big enough impact on the disease.”

Clinical trials in oncology frequently utilize surrogate endpoints like tumor shrinkage rather than focusing on endpoints that directly reflect patient longevity or quality of life.

“two-thirds of cancer drugs are being approved one-third i know they shrink tumors more than 30 in a fraction of people the other third i know they delay tumor growth by 20 and then the other third i know you live longer live better”

It is critical for researchers to control for pre-existing conditions and other health behaviors when studying the effects of alcohol to avoid misleading results.

“one criticism of those um studies showing that low rist drinking is healthy is that the group that is often used as sort of the comparison group are people that don't drink at all but it turns out that many people who don't drink at all may not be drinking because they have chronic health problems”

A study design should include pre-specified primary outcomes to prevent the bias inherent in multiple hypothesis testing.

“it's really important that when people are pre-registering studies they State what the primary outcome is and what the secondary outcomes are and typically a study that fails to meet its primary outcome will be deemed a null study even if it meets secondary outcomes”

A clear, mass spectrometry-based assay for T3 is necessary for accurate clinical management of hypothyroidism.

“We should try for patients with hypothyroidism. We want to normalize T3 in the circulation and we want to make it a reliable method, robust method. And we need the pharmaceutical industry needs to develop a slow release T3.”

Clinical trials are necessary to determine the efficacy of CBD for conditions like brain injury in humans.

“these preclinical studies are very promising we need more human subject data we're trying very hard to get this this quickly it's very expensive to do”

Rigorous clinical trials are necessary to move psychedelic research forward, ensuring safety and efficacy while moving toward formal regulatory approval.

“So I don't see it as a race between the decriminalization or legalization of these compounds versus their medical development.”

The occurrence of mistakes in research and development is evidence that a company is operating on the scientific frontier.

“you need to teach people that the day you stop making mistakes is the evidence you're not on the frontier and so the public needs to be sensitized to what risk means here risk doesn't mean never anything going wrong risk means sometimes stuff goes wrong”

Making mistakes is an essential part of scientific progress and the discovery process in biotechnology.

“I think that's the same with making mistakes in science there's no right or wrong you have to make mistakes”